Coronavirus EGC Extension Act
Official title: A bill to temporarily prevent emerging growth companies from losing their status during the COVID-19 pandemic, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Coronavirus EGC Extension Act
This bill extends the status of an issuer of securities as an emerging growth company. Specifically, these issuers will remain emerging growth companies until the later of
- one year after the date of enactment of this bill,
- the end of the COVID-19 (i.e., coronavirus disease 2019) emergency declaration period, and
- the date the issuer would otherwise cease being an emerging growth company.
Emerging growth companies (in general, a newly public company with revenues below a specified threshold) are subject to reduced disclosure requirements, among other regulations.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4218: Coronavirus EGC Extension Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-4218/
"S. 4218: Coronavirus EGC Extension Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-4218/.
S. 4218, 116th Cong. (2026), https://openamerica.io/bill/116-S-4218/.
[S. 4218: Coronavirus EGC Extension Act](https://openamerica.io/bill/116-S-4218/)